Dosage forms and regimens for amino acid compounds
US12390463B2 · kind B2 · utility
0Cited by
14References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 2022 |
| Grant date | Aug 19, 2025 |
| Priority date | — |
| Expiry date | Aug 29, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I): or a salt thereof, wherein R1, R2, R10, R11, R12, R13, R14, R15, R16, q and p are as described herein. Compounds of formula (A), formula (I), and pharmaceutical compositions thereof are αvβ6 integrin inhibitors that are useful for treating fibrosis such as idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.